News & CommentMolecular Biology

Glaxo to Close Top-Ranked Institute

See allHide authors and affiliations

Science  17 Oct 1997:
Vol. 278, Issue 5337, pp. 379
DOI: 10.1126/science.278.5337.379b

You are currently viewing the summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Summary

PARIS-- Researchers at the prestigious Geneva Biomedical Research Institute (GBRI) are scrambling to find a way to keep their laboratory alive. On 1 October, the institute's owner, the British pharmaceutical giant Glaxo Wellcome, announced that it plans to close the lab by April next year. GBRI researchers say they were given no prior warning.